These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. ADAM15 decreases integrin alphavbeta3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion. Beck V; Herold H; Benge A; Luber B; Hutzler P; Tschesche H; Kessler H; Schmitt M; Geppert HG; Reuning U Int J Biochem Cell Biol; 2005 Mar; 37(3):590-603. PubMed ID: 15618016 [TBL] [Abstract][Full Text] [Related]
25. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
26. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery. Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183 [TBL] [Abstract][Full Text] [Related]
27. Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells. Chang MW; Lo JM; Juan HF; Chang HY; Chuang CY PLoS One; 2012; 7(5):e37935. PubMed ID: 22655084 [TBL] [Abstract][Full Text] [Related]
28. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature. Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307 [TBL] [Abstract][Full Text] [Related]
29. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression. Decristoforo C; Faintuch-Linkowski B; Rey A; von Guggenberg E; Rupprich M; Hernandez-Gonzales I; Rodrigo T; Haubner R Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166 [TBL] [Abstract][Full Text] [Related]
30. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel. Danhier F; Vroman B; Lecouturier N; Crokart N; Pourcelle V; Freichels H; Jérôme C; Marchand-Brynaert J; Feron O; Préat V J Control Release; 2009 Dec; 140(2):166-73. PubMed ID: 19699245 [TBL] [Abstract][Full Text] [Related]
31. RGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapy. Ji S; Xu J; Zhang B; Yao W; Xu W; Wu W; Xu Y; Wang H; Ni Q; Hou H; Yu X Cancer Biol Ther; 2012 Feb; 13(4):206-15. PubMed ID: 22354009 [TBL] [Abstract][Full Text] [Related]
32. Bicyclic RGD Peptides with Exquisite Selectivity for the Integrin α Bernhagen D; Jungbluth V; Quilis NG; Dostalek J; White PB; Jalink K; Timmerman P ACS Comb Sci; 2019 Mar; 21(3):198-206. PubMed ID: 30624885 [TBL] [Abstract][Full Text] [Related]
33. Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel. Emami J; Rezazadeh M; Hasanzadeh F; Sadeghi H; Mostafavi A; Minaiyan M; Rostami M; Davies N Int J Biol Macromol; 2015 Sep; 80():29-40. PubMed ID: 26093319 [TBL] [Abstract][Full Text] [Related]
34. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures. Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508 [TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin alpha v beta 3. Ryppa C; Mann-Steinberg H; Biniossek ML; Satchi-Fainaro R; Kratz F Int J Pharm; 2009 Feb; 368(1-2):89-97. PubMed ID: 18992308 [TBL] [Abstract][Full Text] [Related]
36. (18) F labeled RGD-A7R peptide for dual integrin and VEGF-targeted tumor imaging in mice bearing U87MG tumors. Ma Y; Liang S; Guo J; Guo R; Wang H J Labelled Comp Radiopharm; 2014 Sep; 57(11):627-31. PubMed ID: 25294311 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers. Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522 [TBL] [Abstract][Full Text] [Related]
38. Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging. Liu S Mol Pharm; 2006; 3(5):472-87. PubMed ID: 17009846 [TBL] [Abstract][Full Text] [Related]
39. EGFR-targeted poly(ethylene glycol)-distearoylphosphatidylethanolamine micelle loaded with paclitaxel for laryngeal cancer: preparation, characterization and in vitro evaluation. Ren H; Gao C; Zhou L; Liu M; Xie C; Lu W Drug Deliv; 2015; 22(6):785-94. PubMed ID: 24670093 [TBL] [Abstract][Full Text] [Related]
40. The effect of liposomal size on the targeted delivery of doxorubicin to Integrin αvβ3-expressing tumor endothelial cells. Kibria G; Hatakeyama H; Ohga N; Hida K; Harashima H Biomaterials; 2013 Jul; 34(22):5617-27. PubMed ID: 23623323 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]